Watimar, Rachel .

HRN: 12-50-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2024
CEFUROXIME 1.5GM (VIAL)
05/20/2024
05/21/2024
IV
1.5gm
Q8 X 3 Doses
S/P NSVD (RHU Delivery) With 2nd Deg And Repair; Inc WBC 29.2
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: